You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 15, April 19, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Law and Medicine
 •Quality of Care, Other
 •Alert me on articles by topic

Will Physician-Level Measures of Clinical Performance Be Used in Medical Malpractice Litigation?

Aaron S. Kesselheim, MD, JD; Timothy G. Ferris, MD, MPH; David M. Studdert, LLB, ScD, MPH

JAMA. 2006;295:1831-1834.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Interest in quality measurement of physician performance is increasing.1 Patients seek ways to identify superior and inferior clinicians,2 and moves by health insurers and other purchasers toward "pay for performance" incentive systems are increasing demand for ways to identify and reward excellent or improving clinicians.3 One way to evaluate physician quality is through physician clinical performance assessment (PCPA), defined as "the quantitative assessment of physician performance based on the rates at which their patients experience certain outcomes of care and/or the rates at which physicians adhere to evidence-based processes of care."1 Physician clinical performance assessment programs have been developed by payers, physician professional organizations, and consumer advocacy groups. At the national level, the Centers for Medicare & Medicaid Services and the National Quality Forum have also been active in fostering such initiatives.4

Several obstacles . . . [Full Text of this Article]

Content and Format of PCPA Initiatives

Content

Format

Author Affiliations: Department of Health Policy and Management, Harvard School of Public Health (Drs Kesselheim and Studdert), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School (Dr Kesselheim), and Partners/MGH Institute for Health Policy, Division of General Medicine, Massachusetts General Hospital and Harvard Medical School (Dr Ferris), Boston, Mass.


RELATED LETTERS

Clinical Performance Measures and Medical Malpractice

JAMA. ;296():1589-1589.
FULL TEXT  

Clinical Performance Measures and Medical Malpractice--Reply
and
JAMA. ;296():1589-1590.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Invited Article: Threats to physician autonomy in a performance-based reimbursement system
Larriviere and Bernat
Neurology 2008;70:2338-2342.
ABSTRACT | FULL TEXT  

Physician Specialty Societies And The Development Of Physician Performance Measures
Ferris et al.
Health Aff (Millwood) 2007;26:1712-1719.
ABSTRACT | FULL TEXT  

Clinical Performance Measures and Medical Malpractice
Luft
JAMA 2006;296:1589-1589.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.